Application no. and date | 19824250.5 (espacenet) (Federated) (European Patent Register), 20191211 | Patent/reg. no. and date | DK/EP 3894411, 20240619 | Publication date | 20211020 | Priority no. and date | EP 18212199, 20181213 | EP pub. no. and date |
EP 3894411 20211020 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | P85019DK01 | Inventor | RATNI, Hasane, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, FREI, Beat, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/4196 (2006.01) , A61K 31/46 (2006.01) , A61K 31/501 (2006.01) , A61K 31/506 (2006.01) , A61P 25/28 (2006.01) , A61P 27/16 (2006.01) , C07D 487/04 (2006.01) | Title | 7-phenoxy-N-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazol-2-aminderivater og beslægtede forbindelser som gamma-sekretase-modulatorer til behandling af Alzheimers sygdom | Int. application no. | EP2019084538 | Int. publication no. | WO2020120521 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|